Cas:202825-46-5 Safinamide mesylate manufacturer & supplier

We serve Chemical Name:Safinamide mesylate CAS:202825-46-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Safinamide mesylate

Chemical Name:Safinamide mesylate
CAS.NO:202825-46-5
Synonyms:(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide;N-{4-[(3-Fluorobenzyl)oxy]benzyl}-L-alaninamide methanesulfonate (1:1);Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2S)-, methanesulfonate (1:1);(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide,methanesulfonic acid;PNU-151774E,NW-1015;Safinamide mesylate;(S)-2-(4-(3-fluorobenzyloxy)benzylamino)propanamide,methanesulfonate;(S)-(+)-2-[[4-(3-Fluorobenzoxy)benzyl]amino]propanamide;FCE-28073(R-isomer),PNU-151774E,NW-1015
Molecular Formula:C18H23FN2O5S
Molecular Weight:398.449
HS Code:2924299090

Physical and Chemical Properties:
Melting point:210° (dec)
Boiling point:476.7ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:127.10000
Exact Mass:398.131165
LogP:4.04410

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1 / PGIII
Packing Group:


Contact us for information like (S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,FCE-28073(R-isomer),PNU-151774E,NW-1015 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide Use and application,(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide technical grade,usp/ep/jp grade.


Related News: However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them. Safinamide mesylate manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. Safinamide mesylate supplier Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they��ve been to mainland China in last 14 days. Safinamide mesylate vendor However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them. Safinamide mesylate factory Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.